SignatureFD’s Gilead Sciences GILD Stock Holding History

SignatureFD’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,000	Closed	-$2K	–	2355
2019 Q4	$2K	Buy	+2,000	New	+$130K	﹤0.01%	1879
2019 Q1	–	Sell	-4,200	Closed	-$1K	–	2004
2018 Q4	$1K	Buy	+4,200	New	+$294K	﹤0.01%	1819
2018 Q3	–	Sell	-4,200	Closed	-$26K	–	1944
2018 Q2	$26K	Buy	+4,200	New	+$297K	﹤0.01%	1086

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

SignatureFD's GILD Position: Q2 2026 in Review

SignatureFD increased its Gilead Sciences (GILD) stake by 0.61% in Q2 2026, buying an estimated $20.3K and bringing the position to 25,292 shares worth $3.2M. The position accounts for 0.04% of the portfolio, ranked #173.

SignatureFD first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.5M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

SignatureFD held 25,292 shares of Gilead Sciences worth $3.2M as of Q2 2026.
SignatureFD bought 154 Gilead Sciences shares in Q2 2026, an estimated $20.3K.
Gilead Sciences made up 0.04% of SignatureFD's portfolio in Q2 2026, its #173 holding.
SignatureFD first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
SignatureFD's Gilead Sciences position peaked at $3.5M in Q1 2026.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.